Moderate - Severe Degenerative Disc Disease Evaluation of the Lumbar Spine

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

417

Participants

Timeline

Start Date

August 19, 2022

Primary Completion Date

March 21, 2025

Study Completion Date

August 27, 2025

Conditions
Lumbar Degenerative Disc Disease
Interventions
DRUG

SB-01 For Injection

Intradiscal injection

DRUG

Sham Needle

Sham needle placement

Trial Locations (30)

10016

Pioneer Clinical Research, New York

23235

Virginia iSpine Physicians, Richmond

23454

Gershon Pain Specialists, Virginia Beach

30265

Vista Clinical Research, LLC, Newnan

32205

Coastal Clinical Research, Jacksonville

32789

Conquest Research, Winter Park

32804

Conquest Research, Orlando

32832

Conquest Research, Orlando

33178

Science Connections, LLC, Doral

33603

Tampa Pain Relief Center, Tampa

33614

Florida Pain Relief Group, Tampa

33709

Pain Relief Centers, St. Petersburg

35209

Central Alabama Research, Birmingham

45069

Meta Medical Research Institute, Cincinnati

45432

META Medical Research Institute, Dayton

46278

The Orthopaedic Research Foundation, Inc (OrthoIndy), Indianapolis

67226

Abay Neuroscience Center, Wichita

68144

OrthoNebraska, Omaha

74104

The Orthopedic Center, Tulsa

75701

Precision Spine Care, Tyler

77008

NeuroCare Partners, Houston

77401

HD Research, Bellaire

77598

Tranquil Clinical Research, Webster

78240

South Texas Spinal Clinic, San Antonio

83713

Injury Care Research, Boise

84107

Wasatch Clinical Research, Salt Lake City

84108

University of Utah, Salt Lake City

85013

Evolve Clinical Research, Phoenix

90403

Source Healthcare, Santa Monica

94558

Neurovations Research, Napa

All Listed Sponsors
collaborator

MCRA

INDUSTRY

lead

Spine BioPharma, Inc

INDUSTRY